Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Mesalazine Impurity 04

Mesalazine Impurity 04 is listed in the pharmaceutical impurity collection under CAS 40038-46-8. Its represented structure has formula C13H10N2O3 and a calculated molecular weight of 242.23 g/mol.

2D chemical structure

O H O N N H O

Chemical identity

Catalog name
Mesalazine Impurity 04
Common name
Mesalazine Impurity 04
Chemical name
2-hydroxy-4-phenyldiazenylbenzoic acid
CAS
40038-46-8
SMILES
O=C(O)c1ccc(N=Nc2ccccc2)cc1O
InChI
InChI=1S/C13H10N2O3/c16-12-8-10(6-7-11(12)13(17)18)15-14-9-4-2-1-3-5-9/h1-8,16H,(H,17,18)
InChIKey
NINQFSZAJHGKHE-UHFFFAOYSA-N
Associated API
Mesalazine

Record ID: A4daba405c01a

Computed properties

C13H10N2O3 Molecular formula
242.234 g/molMolecular weight
242.0691 DaMonoisotopic exact mass
82.25 ŲTopological polar surface area
3.5058 Calculated LogP (Wildman–Crippen)
65.6841 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 3 6 9 12 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight242.23428.03
Calculated LogP (Wildman–Crippen)3.505870.84
Topological polar surface area82.2559.78
Hydrogen-bond acceptors450.68
Hydrogen-bond donors264.87
Rotatable bonds (strict)337.08

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC13H10N2O3dimensionless
Molecular weight242.234g/mol
Monoisotopic exact mass242.0691Da
Topological polar surface area82.25Ų
Calculated LogP (Wildman–Crippen)3.5058dimensionless
Molar refractivity (Wildman–Crippen)65.6841cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors2count
Rotatable bonds (strict)3count
Heavy atoms18count
Heteroatoms5count
Rings2count
Aromatic rings2count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area103.0502Ų
Valence electrons90count
Radical electrons0count
Bertz complexity594.4403index
Balaban J2.232index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Mesalazine Impurity 04

Qualification and safety assessment of Mesalazine Impurity 04

Explore toxicological qualification of Mesalazine Impurity 04 and ICH M7 mutagenic impurity assessment of Mesalazine Impurity 04 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Mesalazine Impurity 04 and acceptable intake and limit justification for Mesalazine Impurity 04. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Mesalazine Impurity 04

Explore Altox services and software through the Altox Pharma-Hub.